Effects of molecular weights on the absorption, distribution and urinary excretion of intraperitoneally administrated carboxymethyl chitosan in rats

Journal of Materials Science: Materials in Medicine

Volumn 23, Issue 12, 2012, Pages 2945-2952

  Dong, Wen ^a   Han, Baoqin ^a   Shao, Kai ^a   Yang, Zhao ^a   Peng, Yanfei ^a   Yang, Yan ^a   Liu, Wanshun ^a  

^a OCEAN UNIVERSITY OF CHINA   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BIOMEDICAL MATERIAL; CARBOXYMETHYL CHITOSAN; CLINICAL APPLICATION; DELIVERY SYSTEMS; DRUG CARRIER; DRUG-TARGETING; FLUORESCEIN ISOTHIOCYANATE; GLYCOPOLYMERS; IN-VIVO; INTRAPERITONEAL ADMINISTRATION; INTRAPERITONEALLY; MEDICAL DEVICES; PERIPHERAL TISSUE; PHARMACEUTICAL EXCIPIENT; PREPARATION PROCEDURES; URINARY EXCRETION;

BIOMEDICAL ENGINEERING; BIOMEDICAL EQUIPMENT; BLOOD VESSELS; MOLECULAR WEIGHT DISTRIBUTION; RATS; TISSUE;

CHITOSAN;

BIOMATERIAL; CARBOXYMETHYLCHITOSAN; CHITOSAN DERIVATIVE; FLUORESCEIN ISOTHIOCYANATE; POLYMER; UNCLASSIFIED DRUG;

ABDOMEN; ANIMAL EXPERIMENT; ARTICLE; BLOOD VESSEL; CONTROLLED STUDY; DRUG DEGRADATION; DRUG DELIVERY DEVICE; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG UPTAKE; FEMALE; IN VIVO STUDY; MOLECULAR WEIGHT; NONHUMAN; PRIORITY JOURNAL; QUALITY CONTROL; RAT; URINARY EXCRETION;

ABSORPTION; ANIMALS; CHITOSAN; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG DELIVERY SYSTEMS; FEMALE; FLUORESCEIN-5-ISOTHIOCYANATE; GLYCOPROTEINS; INJECTIONS, INTRAPERITONEAL; MOLECULAR WEIGHT; POLYMERS; RATS; RATS, SPRAGUE-DAWLEY; SOLUBILITY; TIME FACTORS; WATER;

RATTUS;

EID: 84871412372     PISSN: 09574530     EISSN: 15734838     Source Type: Journal    
DOI: 10.1007/s10856-012-4747-7     Document Type: Article

References (29)

1. Agnihotri SA, Mallikarjuna NN, Aminabhavi TM. Recent advances on chitosan-based micro-and nanoparticles in drug delivery. J Control Release. 2004;100:5-28. (Pubitemid 39445982)
2. Kumar MNVR, Muzzarelli RAA, Muzzareilli C, Sashiwa H, Domb A. Chitosan chemistry and pharmaceutical perspectives. J Chem Rev. 2004;104:6017-84. (Pubitemid 40025733)
3. Mourya VK, Inamdar NN. Chitosan-modifications and applications: Opportunities galore. React Funct Polym. 2008;68:1013-51.
4. Khoushab F, Yamabhai M. Chitin research revisited. Mar Drugs. 2010;8:1988-2012.
5. Ji QX, Zhong DY, Lu R, Zhang WQ, Deng J, Chen XG. In vitro evaluation of the biomedical properties of chitosan and quaternized chitosan for dental applications. Carbohydr Res. 2009;344: 1297-302.
6. Chen XG, Wang Z, Liu WS, Park H. The effect of carboxymethyl-chitosan on proliferation and collagen secret ion of normal and keloid skin fibroblasts. Biomaterials. 2002;23:4609-14. (Pubitemid 36151613)
7. Zhu A, Fang N. Adhesion dynamics, morphology, and organization of 3T3 fibroblast on chitosan and its derivative: The effect of O-carboxymethylation. Biomacromolecules. 2005;6:2607-14. (Pubitemid 41388272)
8. Anitha A, Maya S, Deepa N, Chennazhi KP, Nair SV, Tamura H, Jayakumar R. Efficient water soluble O-carboxymethyl chitosan nanocarrier for the delivery of curcumin to cancer cells. Carbohydr Polym. 2011;83:452-61.
9. Liu B, Liu WS, Han BQ, Sun YY. Antidiabetic effects of Chitooligosaccharides on pancreatic islet cells in streptozotocin induced diabetic rats. World J Gastroenterol. 2007;13:725-31.
10. Chen SC, Wu YC, Mi FL, Lin YH, Yu LC, Sung HW. A novel pH-sensitive hydrogel composed of N,O-Carboxymethyl chitosan and alginate crosslinked by genipin for protein drug delivery. J Control Release. 2004;96:285-300.
11. Liu XF, Guan YL, Yang DZ, Li Z, Yao KD. Antibacterial action of chitosan and carboxymethylated chitosan. J Appl Polym Sci. 2001;79:1324-35. (Pubitemid 32138450)
12. Krause TJ, Zazanis G, Malatesta P, Solina A. Prevention of pericardial adhesions with N-O carboxymethylchitosan in the rabbit model. J Invest Surgery. 2001;14:93-7. (Pubitemid 32529850)
13. Chen R, Wang G, Chen C, Ho H, Sheu M. Development of N,O-(carboxymethyl) chitosan/collagen matrixes as a wound dressing. Biomacromolecules. 2006;7:1058-64. (Pubitemid 43670791)
14. Shi X, Du Y, Yang J, Zhang B, Sun L. Effect of degree of substitution and molecular weight of carboxymethyl chitosan nanoparticles on doxorubicin delivery. J Appl Polym Sci. 2006;100:4689-96.
15. Jeong YI, Jin SG, Kim IY, Pei J, Wen M, Jung TY, Moon KS, Jung S. Doxorubicin-incorporated nanoparticles composed of poly(ethylene glycol)-grafted carboxymethyl chitosan and antitumor activity against glioma cells in vitro. Colloids Surf B. 2010;79:149-55.
16. Cui F, Qian F, Zhao Z, Yin L, Tang C, Yin C. Preparation, characterization and oral delivery of insulin loaded carboxylated chitosan grafted poly(methyl methacrylate) nanoparticles. Biomacromolecules. 2009;10:1253-8.
17. Shu SJ, Zhang XG, Teng DY, Wang Z, Li CX. Polyelectrolyte nanoparticles based on water-soluble chitosan-poly(L-aspartic acid)-polyethylene glycol for controlled protein release. Carbohydr Res. 2009;344:1197-204.
18. El-Sherbiny IM, Smyth HDC. Poly(ethylene glycol)-carboxymethyl chitosan-based pH-responsive hydrogels: Photo-induced synthesis, characterization, swelling, and in vitro evaluation as potential drug carriers. Carbohydr Res. 2010;345
19. Zhang YF, Yin P, Zhao XQ, Wang J, Wang J, Wang CD, Ren L, Zhang QQ. O-Carboxymethyl-chitosan/organosilica hybrid nanoparticles as non-viral vectors for gene delivery. Mater Sci Eng, C. 2009;29:2045-9.
20. Geisberger G, Paulus S, Carraro M, Bonchio M, Patzke GR. Synthesis, characterisation and cytotoxicity of polyoxometalate/carboxymethyl chitosan nanocomposites. Chem-Eur J. 2011;17:4619-25.
21. Zeng LT, Qin CQ, Wang W, Chi WL, Li W. Absorption and distribution of chitosan in mice after oral administration. Carbohydr Polym. 2008;71:435-40. (Pubitemid 350181060)
22. Aam BB, Heggset EB, Norberg AL, Sørlie M, Varum KM, Eijsink VGH. Production of chitooligosaccharides and their potential applications in medicine. Mar Drugs. 2010;8:1482-517.
23. Chae SY, Jang MK, Nah JW. Influence of molecular weight on oral absorption of water soluble chitosans. J Control Release. 2005;102:383-94. (Pubitemid 40093761)
24. Kean T, Thanou M. Biodegradation, biodistribution and toxicity of chitosan. Adv Drug Delivery Rev. 2010;62:3-11.
25. Dong W, Han BQ, Feng YL, Song FL, Chang J, Jiang HP, Tang YY, Liu WS. Pharmacokinetics and biodegradation mechanisms of versatile carboxymethyl derivative of chitosan in rats: In vivo and in vitro evaluation. Biomacromolecules. 2010;11:1527-33.
26. Guo Z, Xing R, Liu S, Zhong Z, Ji X, Wang L, Li P. The influence of molecular weight of quaternized chitosan on antifungal activity. Carbohydr Polym. 2008;71:694-7. (Pubitemid 350250830)
27. Huang M, Khor E, Lim LY. Uptake and cytotoxicity of chitosan molecules and nanoparticles: Effects of molecular weight and degree of deacetylation. Pharm Res. 2004;21:344-53. (Pubitemid 38221982)
28. Da Silva CA, Chalouni C, Williams A, Hartl D, Lee CG, Elias JA. Chitin is a size-dependent regulator of macrophage TNF and IL-10 production. J Immunol. 2009;182:3573-82.
29. Reese TA, Liang HE, Tager AM, Luster AD, Van Rooijen N, Voehringer D, Locksley RM. Chitin induces accumulation in tissue of innate immune cells associated with allergy. Nature. 2007;447:92-6. (Pubitemid 46685837)